Noskapin "dak" (Noscapine)

Noscapine, the active ingredient in Noskapin dak, is an antitussive presented as an oral formulation for oral use. It is employed to suppress the cough reflex in patients requiring symptomatic relief of non‑productive cough. The medication is indicated for temporary relief of cough associated with common colds, bronchitis, and other respiratory irritations.

GNH USA supplies Noskapin dak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Noskapin dak is an antitussive that acts on the central cough pathway to reduce cough frequency and severity.

Acute cough: provides symptomatic relief of sudden‑onset cough associated with upper respiratory infections. Chronic non‑productive cough: helps reduce frequency of persistent dry cough when other treatments are unsuitable. Cough due to bronchitis: alleviates cough symptoms during bronchial inflammation.

Noskapin dak may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient light‑headedness. - Drowsiness: increased sleepiness. - Headache: mild cranial discomfort.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or anaphylaxis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Hematologic abnormalities: unexplained bruising or low blood counts. - Seizures: rare occurrence of convulsive episodes.

Before initiating therapy, consider the following safety measures.

Pregnancy: safety not established; use only if potential benefit justifies the risk. Breastfeeding: unknown excretion; weigh benefits against possible infant exposure. Renal impairment: dose may need adjustment; monitor renal function. Drug interactions: review all concomitant medicines for potential interactions. Known hypersensitivity: avoid in patients with documented allergy to noscapine. Store at ambient temperature: keep in the original container, protect from moisture and light.

Noskapin dak can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Opioid antitussives: additive central nervous system depression. - Antihistamines: increased sedation.

Moderate Interactions (Monitor Closely): - CYP450 substrates: noscapine may alter metabolism of certain drugs. - SSRIs and other serotonergic agents: monitor for signs of serotonin syndrome.